{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:22:17Z","timestamp":1792059737335,"version":"4.4.0"},"reference-count":50,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychedelic Studies"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1556\/2054.01.2017.009","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T12:36:08Z","timestamp":1508243768000},"page":"65-73","source":"Crossref","is-referenced-by-count":54,"title":["Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning"],"prefix":"10.1556","volume":"1","author":[{"given":"Alan K.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Barsuglia","sequence":"additional","affiliation":[{"name":"Crossroads Treatment Center, Rosarito, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin-Marley","family":"Windham-Herman","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lynch","sequence":"additional","affiliation":[{"name":"Crossroads Treatment Center, Rosarito, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Polanco","sequence":"additional","affiliation":[{"name":"Crossroads Treatment Center, Rosarito, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref31","first-page":"234","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"The American Journal on Addictions\/American Academy of Psychiatrists in Alcoholism and Addictions,"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Chapter 1. Ibogaine: A review","volume":"56,","author":"Alper","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/17439760701756946","article-title":"The Satisfaction With Life Scale and the emerging construct of life satisfaction","volume":"3","author":"Pavot","year":"2008","journal-title":"Journal of Positive Psychology,"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction,"},{"key":"ref131","first-page":"70","article-title":"Pharmacodynamics and therapeutic applications of iboga and ibogaine","volume":"6,","author":"Goutarel","year":"1993","journal-title":"Psychedelic Monographs and Essays,"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68,","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry,"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cnr.2005.08.012","article-title":"Recent advances in the treatment of opiate addiction","volume":"5","author":"Ling","year":"2005","journal-title":"Clinical Neuroscience Research,"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0099-9598(01)56012-5","article-title":"Ibogaine in the treatment of heroin withdrawal","volume":"56,","author":"Mash","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6,","author":"Brown","year":"2013","journal-title":"Current Drug Abuse Reviews,"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6,","author":"Brown","year":"2013","journal-title":"Current Drug Abuse Reviews,"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/brain\/awq138","article-title":"Alterations in brain structure and functional connectivity in prescription opioid-dependent patients","volume":"133","author":"Upadhyay","year":"2010","journal-title":"Brain,"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: Options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy,"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0099-9598(01)56012-5","article-title":"Ibogaine in the treatment of heroin withdrawal","volume":"56,","author":"Mash","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2009.10.030","article-title":"Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson\u2019s disease","volume":"127","author":"Samoylenko","year":"2010","journal-title":"Journal of Ethnopharmacology,"},{"key":"ref51","author":"Bastiaans","year":"2004","journal-title":"Life after ibogaine: An exploratory study of the long-term effects of ibogaine treatment on drug addicts"},{"key":"ref421","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction","volume":"30,","author":"Veilleux","year":"2010","journal-title":"Clinical Psychology Review,"},{"key":"ref21","first-page":"43","article-title":"The use of ibogaine in the treatment of addictions","author":"Alper","year":"2007","journal-title":"Psychedelic medicine: New evidence for hallucinogenic substances as treatments"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pbb.2011.02.017","article-title":"Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue","volume":"98,","author":"Andersen","year":"2011","journal-title":"Pharmacology, Biochemistry, and Behavior,"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0099-9598(01)56018-6","article-title":"A contemporary history of ibogaine in the United States and Europe","volume":"56,","author":"Alper","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2009.10.030","article-title":"Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson\u2019s disease","volume":"127","author":"Samoylenko","year":"2010","journal-title":"Journal of Ethnopharmacology,"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64,","author":"Bogenschutz","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry,"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"67","DOI":"10.36076\/ppj.2012\/15\/ES67","article-title":"Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse","volume":"15,","author":"Sehgal","year":"2012","journal-title":"Pain Physician,"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: Results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction,"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcph.404","article-title":"Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability","volume":"55","author":"Glue","year":"2015","journal-title":"Journal of Clinical Pharmacology,"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0099-9598(01)56018-6","article-title":"A contemporary history of ibogaine in the United States and Europe","volume":"56,","author":"Alper","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref151","volume-title":"Manual for the Depression Anxiety Stress Scales","author":"Lovibond","year":"1995"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/cpdd.254","article-title":"Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients","volume":"5","author":"Glue","year":"2016","journal-title":"Clinical Pharmacology in Drug Development,"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: Options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Expert Opinion on Pharmacotherapy,"},{"key":"ref371","doi-asserted-by":"crossref","DOI":"10.1515\/9780691196282","volume-title":"Bwiti: An ethnography of the religious imagination in Africa","author":"Fernandez","year":"1982"},{"key":"ref441","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews,"},{"key":"ref321","author":"Bastiaans","year":"2004","journal-title":"Life after ibogaine: An exploratory study of the long-term effects of ibogaine treatment on drug addicts"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"67","DOI":"10.36076\/ppj.2012\/15\/ES67","article-title":"Prescription opioid abuse in chronic pain: A review of opioid abuse predictors and strategies to curb opioid abuse","volume":"15,","author":"Sehgal","year":"2012","journal-title":"Pain Physician,"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcph.404","article-title":"Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability","volume":"55","author":"Glue","year":"2015","journal-title":"Journal of Clinical Pharmacology,"},{"key":"ref231","article-title":"Improvement in physiologic but not hormonal functions after 10 years of opioid treatment","author":"Tennant","year":"2013","journal-title":"29th Annual Meeting of the American Academy of Pain Medicine (AAPM),"},{"key":"ref171","first-page":"CD011117","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews,"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/17439760701756946","article-title":"The Satisfaction With Life Scale and the emerging construct of life satisfaction","volume":"3","author":"Pavot","year":"2008","journal-title":"Journal of Positive Psychology,"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Chapter 1. Ibogaine: A review","volume":"56,","author":"Alper","year":"2001","journal-title":"The Alkaloids. Chemistry and Biology,"},{"key":"ref401","first-page":"70","article-title":"Pharmacodynamics and therapeutic applications of iboga and ibogaine","volume":"6,","author":"Goutarel","year":"1993","journal-title":"Psychedelic Monographs and Essays,"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64,","author":"Bogenschutz","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry,"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pbb.2011.02.017","article-title":"Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue","volume":"98,","author":"Andersen","year":"2011","journal-title":"Pharmacology, Biochemistry, and Behavior,"},{"key":"ref501","article-title":"Improvement in physiologic but not hormonal functions after 10 years of opioid treatment","author":"Tennant","year":"2013","journal-title":"29th Annual Meeting of the American Academy of Pain Medicine (AAPM),"},{"key":"ref301","first-page":"234","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"The American Journal on Addictions\/American Academy of Psychiatrists in Alcoholism and Addictions,"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/cpdd.254","article-title":"Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients","volume":"5","author":"Glue","year":"2016","journal-title":"Clinical Pharmacology in Drug Development,"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial","volume":"68,","author":"Weiss","year":"2011","journal-title":"Archives of General Psychiatry,"},{"key":"ref101","doi-asserted-by":"crossref","DOI":"10.1515\/9780691196282","volume-title":"Bwiti: An ethnography of the religious imagination in Africa","author":"Fernandez","year":"1982"},{"key":"ref291","first-page":"43","article-title":"The use of ibogaine in the treatment of addictions","author":"Alper","year":"2007","journal-title":"Psychedelic medicine: New evidence for hallucinogenic substances as treatments"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction","volume":"30,","author":"Veilleux","year":"2010","journal-title":"Clinical Psychology Review,"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cnr.2005.08.012","article-title":"Recent advances in the treatment of opiate addiction","volume":"5","author":"Ling","year":"2005","journal-title":"Clinical Neuroscience Research,"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/brain\/awq138","article-title":"Alterations in brain structure and functional connectivity in prescription opioid-dependent patients","volume":"133","author":"Upadhyay","year":"2010","journal-title":"Brain,"}],"container-title":["Journal of Psychedelic Studies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.akademiai.com\/doi\/full-xml\/10.1556\/2054.01.2017.009","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akademiai.com\/doi\/full\/10.1556\/2054.01.2017.009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T20:00:12Z","timestamp":1659643212000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/2054.01.2017.009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1556\/2054.01.2017.009"],"URL":"https:\/\/doi.org\/10.1556\/2054.01.2017.009","relation":{},"ISSN":["2559-9283"],"issn-type":[{"value":"2559-9283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}